In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 5, 1999, Pages 653-659

  Cirioni, Oscar ^a   Giacometti, Andrea ^b   Barchiesi, Francesco ^b   Fortuna, Moira ^b   Scalise, Giorgio ^b  

^a Azienda Ospedaliera Umberto I   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; CLARITHROMYCIN; COTRIMOXAZOLE; ETOPOSIDE; MINOCYCLINE; PYRIMETHAMINE; RIFABUTIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYST; DILUTION; DRUG ACTIVITY; DRUG CONCENTRATION; DRUG POTENTIATION; DRUG SENSITIVITY; IN VITRO STUDY; INCUBATION TIME; MONOLAYER CULTURE; PNEUMOCYSTIS CARINII; PROPHYLAXIS; TROPHOZOITE;

ALBENDAZOLE; ANTIFUNGAL AGENTS; CELL LINE; CLARITHROMYCIN; DRUG SYNERGISM; ETOPOSIDE; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PNEUMOCYSTIS; RIFABUTIN; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0032714424     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.5.653     Document Type: Article

References (24)

1. Lane, H. C., Laughon, B. E., Falloon, J., Kovacs, J. A., Davey, R. T., Polis, M. A. et al. (1994). Recent advances in the management of AIDS-related opportunistic infections. NIH conference. Annals of Internal Medicine 120, 945-55.
2. Cushion, M. T., Chen, F. & Kloepfer, N. (1997). A cytotoxicity assay for evaluation of candidate anti-Pneumocystis carinii agents. Antimicrobial Agents and Chemotherapy 41, 379-84.
3. Walzer, P. D., Runck, J., Orr, S., Foy, J., Steele, P. & White, M. (1997). Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficacies. Antimicrobial Agents and Chemotherapy 41, 242-50.
4. Morris-Jones, S. P. & Easterbrook, P. J. (1997). Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection. Journal of Antimicrobial Chemotherapy 40, 315-8.
5. Walzer, P. D., Foy, J., Steele, P., Kim, C. K., White, M., Klein, R. S. et al. (1992). Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy 36, 1935-42.
6. Cirioni, O., Giacometti, A. & Scalise, G. (1997). In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii. Journal of Antimicrobial Chemotherapy 39, 45-51.
7. Chaisson, R. E. (1996). Potential role of rifabutin in prophylaxis for tuberculosis and infections due to multiple opportunistic pathogens. Clinical Infectious Diseases 22, Suppl. 1, S61-6.
8. Blanshard, C., Ellis, D. S., Tovej, D. G., Dowell, S. & Gazzard, B. G. (1992). Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS 6, 311-3.
9. Dieterich, D. T., Lew, E. A., Kotler, D. P., Poles, M. A. & Orenstein, J. M. (1994). Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. Journal of Infectious Diseases 169, 178-83.
10. Bartlett, M. S., Edlind, T. D., Lee, C. H., Dean, R., Queener, S. F., Shaw, M. M. et al. (1994). Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice. Antimicrobial Agents and Chemotherapy 38, 1834-7.
11. Alder, J., Mitten, M., Shipkowitz, N., Hernandez, L., Hui, J. H., Marsh, K. et al. (1994). Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole. Journal of Antimicrobial Chemotherapy 33, 253-63.
12. Toma, E., Fournier, S., Dumont, M., Bolduc, P. & Deschamps, H. (1993). Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial. Clinical Infectious Diseases 17, 178-84.
13. Comley, J. C. W. & Sterling, A. M. (1995). Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice. Antimicrobial Agents and Chemotherapy 39, 806-11.
14. Kaneshiro, E. S., Wu, Y. P. & Cushion, M. T. (1991). Assays lor testing Pneumocystis carinii viability. Journal of Protozoology 38, Suppl., 85-7.
15. Kaplan, J. E., Masur, H., Holmes, K. K., McNeil, M. M., Schonberger, L. B., Navin, T. R. et al. (1995). USPHS/IDSA guidelines for the prevention of opportunistic infections in person infected with Human Immunodeficiency Virus: introduction. Clinical Infectious Diseases 21, Suppl. 1, S1-11.
16. Locke, A., Meshnick, S., Lane, B., Cannon, M., Kileen, A., Beals, T. et al. (1997). Mutations in Pneumocystis carinii associated with prophylaxis breakthroughs in AIDS patients. In Proceedings of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997. Abstract No. 3.
17. Venkatesan, P. (1998). Albendazole. Journal of Antimicrobial Chemotherapy 41, 145-7.
18. Bartlett, M. S., Edlind, T. D., Durkin, M. M., Shaw, M. M., Queener, S. F. & Smith, J. W. (1992). Antimicrotubule benzimidazoles inhibit in vitro growth of Pneumocystis carinii. Antimicrobial Agents and Chemotherapy 36, 779-82.
19. Kunin, C. M. (1996). Antimicrobial activity of rifabutin. Clinical of Infectious Diseases 22, Suppl. 1, S3-S14.
20. Holmberg, S. D., Moorman, A. C., Von Bargen, J. C., Palella, F. J., Loveless, M. O., Ward, D. J. et al. (1998). Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. Journal of the American Medical Association 279, 384-6.
21. Araujo, F. G., Slifer, T. & Remington, J. S. (1994). Rifabutin is active in murine models of toxoplasmosis. Antimicrobial Agents and Chemotherapy 38, 570-5.
22. Brun Pascaud, M., Chau, F., Rajagopalan-Levasseur, P., Derouin, F. & Girard, P. M. (1996). Evaluation of the activities of rifabutin combined with atovaquone or low-doses of cotrimoxazole for prevention of pneumocystosis and toxoplasmosis in a dual infection rat model. Journal of Eukaryotic Microbiology 43, S14-5.
23. Kent, R.J., Bakhtiar, M. & Shanson, D. C. (1992). The in-vitro bactericidal activities of combinations of antimicrobial agents against clinical isolates of Mycobacterium avium-intracellulare. Journal of Antimicrobial Chemotherapy 30, 643-50.
24. Sullam, P. M. (1996). Rifabutin therapy for disseminated Mycobacterium avium complex infection. Clinical of Infectious Diseases 22, Suppl. 1, S37-S42.